353 related articles for article (PubMed ID: 21169067)
1. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
Di Pauli F; Mader S; Rostasy K; Schanda K; Bajer-Kornek B; Ehling R; Deisenhammer F; Reindl M; Berger T
Clin Immunol; 2011 Mar; 138(3):247-54. PubMed ID: 21169067
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
Pröbstel AK; Dornmair K; Bittner R; Sperl P; Jenne D; Magalhaes S; Villalobos A; Breithaupt C; Weissert R; Jacob U; Krumbholz M; Kuempfel T; Blaschek A; Stark W; Gärtner J; Pohl D; Rostasy K; Weber F; Forne I; Khademi M; Olsson T; Brilot F; Tantsis E; Dale RC; Wekerle H; Hohlfeld R; Banwell B; Bar-Or A; Meinl E; Derfuss T
Neurology; 2011 Aug; 77(6):580-8. PubMed ID: 21795651
[TBL] [Abstract][Full Text] [Related]
3. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
Hennes EM; Baumann M; Schanda K; Anlar B; Bajer-Kornek B; Blaschek A; Brantner-Inthaler S; Diepold K; Eisenkölbl A; Gotwald T; Kuchukhidze G; Gruber-Sedlmayr U; Häusler M; Höftberger R; Karenfort M; Klein A; Koch J; Kraus V; Lechner C; Leiz S; Leypoldt F; Mader S; Marquard K; Poggenburg I; Pohl D; Pritsch M; Raucherzauner M; Schimmel M; Thiels C; Tibussek D; Vieker S; Zeches C; Berger T; Reindl M; Rostásy K;
Neurology; 2017 Aug; 89(9):900-908. PubMed ID: 28768844
[TBL] [Abstract][Full Text] [Related]
5. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
[TBL] [Abstract][Full Text] [Related]
6. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.
López-Chiriboga AS; Majed M; Fryer J; Dubey D; McKeon A; Flanagan EP; Jitprapaikulsan J; Kothapalli N; Tillema JM; Chen J; Weinshenker B; Wingerchuk D; Sagen J; Gadoth A; Lennon VA; Keegan BM; Lucchinetti C; Pittock SJ
JAMA Neurol; 2018 Nov; 75(11):1355-1363. PubMed ID: 30014148
[TBL] [Abstract][Full Text] [Related]
7. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
Baumann M; Sahin K; Lechner C; Hennes EM; Schanda K; Mader S; Karenfort M; Selch C; Häusler M; Eisenkölbl A; Salandin M; Gruber-Sedlmayr U; Blaschek A; Kraus V; Leiz S; Finsterwalder J; Gotwald T; Kuchukhidze G; Berger T; Reindl M; Rostásy K
J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):265-72. PubMed ID: 25121570
[TBL] [Abstract][Full Text] [Related]
8. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.
Ketelslegers IA; Van Pelt DE; Bryde S; Neuteboom RF; Catsman-Berrevoets CE; Hamann D; Hintzen RQ
Mult Scler; 2015 Oct; 21(12):1513-20. PubMed ID: 25662345
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease.
Brilot F; Dale RC; Selter RC; Grummel V; Kalluri SR; Aslam M; Busch V; Zhou D; Cepok S; Hemmer B
Ann Neurol; 2009 Dec; 66(6):833-42. PubMed ID: 20033986
[TBL] [Abstract][Full Text] [Related]
10. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
O'Connor KC; McLaughlin KA; De Jager PL; Chitnis T; Bettelli E; Xu C; Robinson WH; Cherry SV; Bar-Or A; Banwell B; Fukaura H; Fukazawa T; Tenembaum S; Wong SJ; Tavakoli NP; Idrissova Z; Viglietta V; Rostasy K; Pohl D; Dale RC; Freedman M; Steinman L; Buckle GJ; Kuchroo VK; Hafler DA; Wucherpfennig KW
Nat Med; 2007 Feb; 13(2):211-7. PubMed ID: 17237795
[TBL] [Abstract][Full Text] [Related]
11. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.
Tomassini V; De Giglio L; Reindl M; Russo P; Pestalozza I; Pantano P; Berger T; Pozzilli C
Mult Scler; 2007 Nov; 13(9):1086-94. PubMed ID: 17468447
[TBL] [Abstract][Full Text] [Related]
12. Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related Diseases.
Spadaro M; Meinl E
Methods Mol Biol; 2016; 1304():99-104. PubMed ID: 25814289
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and biochemical characteristics of atypical variants of multiple sclerosis].
Shchepareva ME; Skalnaya AA; Zakharova MN; Shabalina AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10. Vyp. 2):81-86. PubMed ID: 31934992
[TBL] [Abstract][Full Text] [Related]
15. Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children.
Lalive PH; Häusler MG; Maurey H; Mikaeloff Y; Tardieu M; Wiendl H; Schroeter M; Hartung HP; Kieseier BC; Menge T
Mult Scler; 2011 Mar; 17(3):297-302. PubMed ID: 21177754
[TBL] [Abstract][Full Text] [Related]
16. Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis.
O'Connor KC; Lopez-Amaya C; Gagne D; Lovato L; Moore-Odom NH; Kennedy J; Krupp L; Tenembaum S; Ness J; Belman A; Boyko A; Bykova O; Mah JK; Stoian CA; Waubant E; Kremenchutzky M; Ruggieri M; Bardini MR; Rensel M; Hahn J; Weinstock-Guttman B; Yeh EA; Farrell K; Freedman MS; Iivanainen M; Bhan V; Dilenge M; Hancock MA; Gano D; Fattahie R; Kopel L; Fournier AE; Moscarello M; Banwell B; Bar-Or A
J Neuroimmunol; 2010 Jun; 223(1-2):92-9. PubMed ID: 20381173
[TBL] [Abstract][Full Text] [Related]
17. Detection of anti-Nogo receptor autoantibody in the serum of multiple sclerosis and controls.
Onoue H; Satoh JI; Ogawa M; Tabunoki H; Yamamura T
Acta Neurol Scand; 2007 Mar; 115(3):153-60. PubMed ID: 17295709
[TBL] [Abstract][Full Text] [Related]
18. Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults.
Wang H; Munger KL; Reindl M; O'Reilly EJ; Levin LI; Berger T; Ascherio A
Neurology; 2008 Oct; 71(15):1142-6. PubMed ID: 18753473
[TBL] [Abstract][Full Text] [Related]
19. Patterns and utility of myelin oligodendrocyte glycoprotein (MOG) antibody testing in cerebrospinal fluid.
Burton JM; Youn S; Al-Ani A; Costello F
J Neurol; 2024 May; 271(5):2662-2671. PubMed ID: 38366070
[TBL] [Abstract][Full Text] [Related]
20. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis.
Sun J; Link H; Olsson T; Xiao BG; Andersson G; Ekre HP; Linington C; Diener P
J Immunol; 1991 Mar; 146(5):1490-5. PubMed ID: 1899688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
